corona
viru
diseas
rapidli
becom
sever
public
health
issu
world
despit
respiratori
symptom
hepat
injuri
also
observ
clinic
set
studi
aim
investig
risk
factor
involv
hepat
injuri
patient
method
total
hospit
patient
diagnos
beij
youan
hospit
retrospect
analyz
accord
liver
function
divid
alt
normal
group
alt
elev
group
clinic
featur
laboratori
data
compar
two
group
independ
risk
factor
liver
injuri
analyz
result
patient
hepat
injuri
studi
account
patient
alt
elev
group
older
alt
normal
group
level
lactic
acid
crp
myoglobin
neutrophil
significantli
higher
alt
elev
group
lymphocyt
albumin
significantli
lower
alt
elev
group
proport
sever
critic
patient
alt
elev
group
significantli
higher
multivari
logist
regress
analysi
show
crp
mgl
lymphocyt
count
independ
relat
hepat
injuri
lymphopenia
crp
may
serv
risk
factor
relat
hepat
injuri
patient
might
relat
inflammatori
cytokin
storm
liver
injuri
earli
detect
time
treatment
hepat
injuri
patient
necessari
corona
viru
diseas
covid
sever
public
health
issu
world
newli
emerg
infecti
diseas
caus
novel
coronaviru
may
develop
acut
respiratori
distress
syndrom
multipl
organ
failur
report
novel
coronaviru
identifi
speci
sever
acut
respiratori
syndrom
relatedcoronaviru
sarsrcov
belong
betacoronaviru
famili
share
sequenc
ident
sarscov
base
phylogeni
taxonomi
establish
practic
offici
name
diseas
caus
name
despit
atyp
pneumonia
primari
symptom
liver
dysfunct
also
observ
mani
clinic
case
indic
possibl
patient
may
caus
hepat
injuri
except
part
patient
receiv
lopinavirritonavir
hospit
caus
druginduc
hepat
injuri
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
inform
consent
waiv
irb
studi
retrospect
assess
laboratori
data
patient
admiss
collect
laboratori
assess
consist
complet
blood
count
blood
chemistri
coagul
test
liver
renal
function
creactiv
protein
procalcitonin
lactic
acid
cardiac
marker
age
day
repres
median
rang
categor
variabl
number
laboratori
data
mean
interquartil
rang
compar
differ
two
group
ttest
chisquar
test
mannwhitney
u
test
logist
regress
use
select
independ
risk
factor
affect
abnorm
liver
function
analys
perform
use
spss
statist
packag
spss
inc
chicago
il
usa
pvalu
consid
statist
signific
characterist
patient
present
studi
shown
tabl
median
age
patient
year
old
sex
ratio
similar
averag
alt
valu
averag
valu
total
bilirubin
direct
bilirubin
normal
rang
averag
level
creatinin
normal
creactiv
protein
increas
significantli
averag
valu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
lymphocyt
close
normal
low
valu
median
valu
creatin
kinas
normal
term
clinic
classif
proport
patient
ordinari
type
follow
sever
critic
patient
patient
abnorm
liver
function
whole
process
hospit
account
includ
elev
alt
ast
patient
abnorm
liver
function
whole
process
hospit
mild
medium
elev
alt
six
patient
chronic
hepat
diseas
enrol
studi
abnorm
liver
function
two
patient
hbv
infect
two
patient
alcohol
liver
diseas
one
moder
elev
alt
within
one
week
admiss
one
liver
injuri
two
patient
fatti
liver
one
patient
mild
liver
injuri
admiss
one
liver
injuri
day
admiss
result
shown
tabl
median
age
two
group
statist
differ
alt
elev
group
year
old
alt
normal
group
year
old
compar
patient
normal
liver
function
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
elev
alt
like
drink
histori
albumin
alt
elev
group
significantli
lower
alt
normal
group
vs
p
bilirubin
level
normal
two
group
level
lactic
acid
significantli
higher
alt
elev
group
vs
p
number
lymphocyt
alt
elev
group
significantli
lower
alt
normal
group
vs
p
howev
level
crp
significantli
higher
alt
normal
group
vs
p
time
number
neutrophil
myoglobin
also
increas
alt
elev
group
alt
normal
group
proport
sever
critic
patient
alt
elev
group
significantli
higher
reach
multivari
logist
regress
perform
analyz
factor
includ
age
drink
histori
baselin
albumin
lactic
acid
crp
neutrophil
myoglobin
clinic
classif
found
crp
mgl
lymphocyt
count
independ
relat
alt
elev
tabl
present
studi
mainli
focus
risk
factor
involv
hepat
injuri
patient
exclud
patient
receiv
drug
may
caus
liver
damag
lopinavirritonavir
accord
find
first
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
time
found
level
lymphopenia
crp
independ
associ
hepat
injuri
studi
suggest
inflammatori
cytokin
storm
might
major
mechan
number
patient
continu
rise
liver
injuri
frequent
report
extrapulmonari
clinic
featur
recent
studi
reveal
nearli
half
patient
experienc
differ
degre
liver
injuri
howev
far
know
studi
factor
liver
injuri
sar
use
cell
entri
receptor
angiotensin
convert
enzymeii
express
liver
tissu
well
late
research
show
bile
duct
cell
higher
specif
express
angiotensin
convert
enzymeii
hepatocyt
indic
possibl
infect
bile
duct
cell
directli
caus
hepat
injuri
suggest
bile
duct
epitheli
cell
may
play
key
role
immunoreact
howev
clinic
data
two
research
show
bile
duct
injuri
relat
index
alkalin
phosphatas
gammaglutamyl
transpeptidas
total
bilirubin
increas
significantli
studi
hepat
injuri
patient
mainli
reflect
mild
medium
elev
alt
level
serum
tbil
almost
normal
moreov
patholog
result
liver
biopsi
show
moder
microvascular
steatosi
activ
inflamm
hepat
lobul
portal
area
due
use
lopinavirritonavir
treatment
difficult
distinguish
reason
liver
injuri
accord
patholog
result
although
cell
entri
receptor
angiotensin
convert
enzymeii
highli
express
bile
duct
cell
recent
work
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
find
suggest
infect
caus
obviou
bile
duct
injuri
thu
infect
may
major
reason
relat
liver
injuri
studi
total
patient
abnorm
liver
function
whole
process
hospit
account
show
alt
elev
admiss
among
patient
present
hepat
injuri
one
moder
elev
alt
other
mild
liver
injuri
alt
result
suggest
hepat
injuri
seriou
begin
diseas
consist
previou
research
compar
studi
higher
proport
patient
liver
injuri
admiss
might
relat
number
sampl
differ
period
onset
hospit
studi
among
patient
present
abnorm
liver
function
present
studi
moder
sever
type
patient
like
liver
injuri
account
indic
consist
academician
nanshan
zhong
recent
clinic
research
acut
respiratori
syndrom
caus
involv
largest
scale
data
far
suggest
hepat
injuri
like
occur
patient
critic
care
moreov
studi
posit
correl
relationship
lymphopenia
liver
injuri
base
previou
studi
lymphopenia
typic
laboratori
indic
highli
pathogen
coronaviru
infect
sarscov
merscov
infect
believ
associ
diseas
sever
recent
studi
reveal
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
infect
patient
sever
diseas
lymphopenia
low
level
lymphocyt
count
patient
associ
mortal
outcom
therefor
result
suggest
occurr
hepat
injuri
relat
deterior
diseas
dynam
process
addit
six
case
chronic
hepat
diseas
enrol
studi
howev
signific
differ
abnorm
liver
function
group
normal
liver
function
group
might
relat
fact
inpati
ordinari
type
previou
studi
shown
inflammatori
cytokin
storm
associ
sever
lung
injuri
advers
outcom
sarscov
merscov
infect
inflammatori
cytokin
storm
overact
inflammatori
respons
human
bodi
caus
viru
infect
lead
persist
activ
reproduct
lymphocyt
macrophag
secret
huge
amount
inflammatori
cytokin
inflammatori
cytokin
storm
lead
pulmonari
injuri
also
injuri
nonpulmonari
organ
includ
liver
kidney
cardiac
muscl
studi
found
liver
damag
common
patient
sever
pneumonia
suspect
associ
inflammatori
factor
storm
studi
patient
liver
damag
higher
elev
crp
level
typic
inflammatori
index
crp
acut
phase
protein
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
count
lymphocyt
cell
especi
cell
well
increas
level
peripher
blood
patient
cell
count
drop
lowest
level
serum
level
inflammatori
cytokin
reach
peak
day
onset
suggest
inflammatori
cytokin
involv
process
earli
stage
explain
reason
patient
mild
liver
injuri
compar
inflammatori
damag
lung
inflammatori
damag
liver
rel
mild
autopsi
analysi
result
may
explain
one
develop
liver
failur
sever
hepat
studi
even
sever
case
patient
liver
injuri
whole
process
hospit
mild
medium
elev
alt
liver
protect
treatment
liver
function
patient
improv
within
one
two
week
studi
also
observ
patient
declin
serum
albumin
though
obviou
differ
two
group
like
due
patient
hyper
metabol
state
present
fever
malnutrit
low
calor
intak
suggest
import
nutrit
support
therapi
moreov
hyperlactatemia
reflect
hypoxia
injuri
may
relat
liver
injuri
result
show
hyperlactatemia
relat
liver
injuri
turn
neg
multivari
analysi
chang
result
may
relat
sampl
size
need
studi
confirm
limit
studi
data
collect
singl
center
certain
timepoint
sampl
size
rel
limit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
largesampl
cohort
studi
still
need
verifi
futur
conclus
hepat
injuri
like
complic
infect
inflammatori
cytokin
storm
may
major
mechan
earli
detect
time
treatment
help
recoveri
liver
function
author
declar
conflict
interest
regard
public
paper
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
